Rights and permissions
About this article
Cite this article
Atorvastatin has ‘most favorable risk-benefit ratio’ of statins. Inpharma Wkly. 1132, 20 (1998). https://doi.org/10.2165/00128413-199811320-00036
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199811320-00036